Are There Any Racial and Ethnic Differences in Response to Medicines in Japanese Patients?
Saved in:
| Published in | Journal of Atherosclerosis and Thrombosis Vol. 22; no. 6; pp. 550 - 552 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | English |
| Published |
Japan
Japan Atherosclerosis Society
01.01.2015
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1340-3478 1880-3873 1880-3873 |
| DOI | 10.5551/jat.ED013 |
Cover
| Author | Nakagawa, Yoshihisa |
|---|---|
| Author_xml | – sequence: 1 fullname: Nakagawa, Yoshihisa organization: Department of Cardiology, Tenri Hospital |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25854531$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kDtPAzEQhC0E4l3wB5BLKAJ-nH2bCkUhvAQCIWhoLJ9vjzi6-MLZKfj3mATSzI40365Wc0C2QxeQkBPOLpRS_HJm08XkmnG5RfY5ABtIKOV29rLIvihhjxzEOGNMSqXELtkTClShJN8nH6Me6dsUs47CN321ztuW2lDTSZoG7-i1b5qcBoeR-kBfMS66EJGmjj5h7Z0P6-DBLmy2SF9s8hhSvDoiO41tIx7_zUPyfjN5G98NHp9v78ejx4ETQ5YGAE2NolJcA5RclFpXGlUNRVNwULYBiQDDspACZWkLW1W6ApBSIxca2VAekrP13UXffS0xJjP30WHb5n-6ZTRcD5nggivI6OkfuqzmWJtF7-e2_zb_fWTgfA24vouxx2aDcGZ-uza5a7PqOrNXa3YWk_3EDWn75F2LK1IIo39ltbFJ3NT2BoP8AUnahcU |
| Cites_doi | 10.1111/j.1538-7836.2006.02237.x 10.1253/circj.CJ-13-1482 10.1161/CIRCULATIONAHA.107.740324 10.1253/circj.CJ-14-0266 10.1016/j.jaci.2013.10.040 10.1056/NEJMoa0706482 10.1253/circj.CJ-12-0454 |
| ContentType | Journal Article |
| Copyright | 2015 Japan Atherosclerosis Society |
| Copyright_xml | – notice: 2015 Japan Atherosclerosis Society |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.5551/jat.ED013 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1880-3873 |
| EndPage | 552 |
| ExternalDocumentID | 25854531 10_5551_jat_ED013 article_jat_22_6_22_ED013_article_char_en |
| Genre | Comment Editorial Commentary |
| GroupedDBID | --- .55 29J 2WC 53G 5GY 5VS AAFWJ ACGFO ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z F5P GX1 JMI JSF JSH KQ8 OK1 OVT P6G RJT RNS RZJ TR2 X7M 3O- AAYXX AOIJS CITATION HYE RPM TKC CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c290t-88fde2b51688712766b6e5d84f4185af83e8897432e37a4abb6b88336e126e093 |
| ISSN | 1340-3478 1880-3873 |
| IngestDate | Fri Jul 11 07:07:11 EDT 2025 Thu Apr 03 07:04:52 EDT 2025 Tue Jul 01 02:27:08 EDT 2025 Wed Sep 03 06:29:49 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 6 |
| Language | English |
| License | https://creativecommons.org/licenses/by-nc-sa/4.0/deed.ja |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c290t-88fde2b51688712766b6e5d84f4185af83e8897432e37a4abb6b88336e126e093 |
| Notes | SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jat/22/6/22_ED013/_article/-char/en |
| PMID | 25854531 |
| PQID | 1690212158 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | proquest_miscellaneous_1690212158 pubmed_primary_25854531 crossref_primary_10_5551_jat_ED013 jstage_primary_article_jat_22_6_22_ED013_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-01-01 |
| PublicationDateYYYYMMDD | 2015-01-01 |
| PublicationDate_xml | – month: 01 year: 2015 text: 2015-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Japan |
| PublicationPlace_xml | – name: Japan |
| PublicationTitle | Journal of Atherosclerosis and Thrombosis |
| PublicationTitleAlternate | JAT |
| PublicationYear | 2015 |
| Publisher | Japan Atherosclerosis Society |
| Publisher_xml | – name: Japan Atherosclerosis Society |
| References | 6) Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M: Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation -- the J-ROCKET AF study --. Circ J, 2012; 76: 2104-2111 7) Burroughs VJ, Maxey RW, Levy RA: Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc, 2002; 94: 1-26 2) Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM: TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med, 2007; 357: 2001-2015 9) Ortega VE, Meyers DA: Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol, 2014; 133: 16-26 5) Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S: PRASFIT-Elective Investigators. Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease under-going elective percutaneous coronary intervention. Circ J, 2014; 78: 2926-2934 8) Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR: Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost, 2006; 4: 2629-2635 1) Wiviott SD, Trenk D, Frelinger AL, O’Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E: Prasugrel compared with high loading- and maintenancedose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation, 2007; 116: 2923-2932 3) Kimura T, Isshiki T, Ogawa H, Yokoi H, Yamaguchi T, Ikeda Y: Randomized, Double-Blind, Dose-Finding, Phase Ⅱ Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention. J Atheroscler Thromb, 2015; 22: 557-569 4) Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Nakamura M: Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J, 2014; 78: 1684-1692 1 2 3 4 5 6 7 8 25737192 - J Atheroscler Thromb. 2015;22(6):557-69 |
| References_xml | – reference: 2) Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM: TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med, 2007; 357: 2001-2015 – reference: 6) Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Ueda H, Iwamoto K, Tajiri M: Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation -- the J-ROCKET AF study --. Circ J, 2012; 76: 2104-2111 – reference: 9) Ortega VE, Meyers DA: Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol, 2014; 133: 16-26 – reference: 1) Wiviott SD, Trenk D, Frelinger AL, O’Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E: Prasugrel compared with high loading- and maintenancedose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation, 2007; 116: 2923-2932 – reference: 3) Kimura T, Isshiki T, Ogawa H, Yokoi H, Yamaguchi T, Ikeda Y: Randomized, Double-Blind, Dose-Finding, Phase Ⅱ Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention. J Atheroscler Thromb, 2015; 22: 557-569 – reference: 4) Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Nakamura M: Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J, 2014; 78: 1684-1692 – reference: 5) Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S: PRASFIT-Elective Investigators. Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease under-going elective percutaneous coronary intervention. Circ J, 2014; 78: 2926-2934 – reference: 8) Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR: Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study. J Thromb Haemost, 2006; 4: 2629-2635 – reference: 7) Burroughs VJ, Maxey RW, Levy RA: Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc, 2002; 94: 1-26 – ident: 7 doi: 10.1111/j.1538-7836.2006.02237.x – ident: 3 doi: 10.1253/circj.CJ-13-1482 – ident: 1 doi: 10.1161/CIRCULATIONAHA.107.740324 – ident: 4 doi: 10.1253/circj.CJ-14-0266 – ident: 6 – ident: 8 doi: 10.1016/j.jaci.2013.10.040 – ident: 2 doi: 10.1056/NEJMoa0706482 – ident: 5 doi: 10.1253/circj.CJ-12-0454 – reference: 25737192 - J Atheroscler Thromb. 2015;22(6):557-69 |
| SSID | ssj0033552 |
| Score | 2.0380716 |
| SourceID | proquest pubmed crossref jstage |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 550 |
| SubjectTerms | Female Hemorrhage - drug therapy Humans Male Myocardial Infarction - complications Percutaneous Coronary Intervention - adverse effects Platelet Aggregation - drug effects Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - therapeutic use |
| Title | Are There Any Racial and Ethnic Differences in Response to Medicines in Japanese Patients? |
| URI | https://www.jstage.jst.go.jp/article/jat/22/6/22_ED013/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/25854531 https://www.proquest.com/docview/1690212158 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Journal of Atherosclerosis and Thrombosis, 2015/06/16, Vol.22(6), pp.550-552 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgIMQL4k65ySBeUxLHTtwnNLGiadJ46qTCS2S3zpohGtRmQuLX8x07ybIC0tiL1Sapk_j7enx8fC6MvZPa2dyqONLLpY0k5uTILvI8WsQqtpjR0tRSgPPx5-zwRB7N1fzCpuujSxo7Xvz6a1zJdVDFMeBKUbL_gWzfKQ7gM_BFC4TRXgnj_Y0jl4kN5RaBLm28-Zss4dNmRYVtDtrqJ8Hrikz15A_ri2Uct3vq_sQRZkyqREkJ-yvvWXHZ3W-otZLCWG_xIGirkOB5ttrU3y197U3L5ps5NT-9Yvql3q6qVbU1QwNDonYMDP4R_ui99SkdSM5UQqDLUI9n7MIxCAdK3psOxa0QA1oNZacKGWjbaViFxLa7El6BTb6yQDOeHsQhjHUnYXYLR4FrCiGKjBp_bdGdoYA28OcmuyVyaFwUIj7vHYNSaGB-j7x7oZCPim78vr_tJS3m9hkU-VP37zWK11Vm99m9Fi6-Hx7kAbvh1g_ZnQ7yR-wriMM9cTiIwwNxOKDkgTh8QBxerXlHHN7UvCcOneiIwzvifHjMTj5NZx8Po7bIRrQQk7iJtC6XTliVZJhuEhoPmzm11LKktEam1KnTGovOVLg0N9JYm1kqUJ25RGQunqRP2N66XrtnjEOTz0pZJkZNnMRPjZQ55R8sXZwtoBmO2Ntu0IofIZdKgTUojawHy4_siOkwnP0lV8ZzxN50ABQQkrTzhTGoz7cF7QULyqOiR-xpQKbvXmDBLDETPb_-jV-wuxd_nJdsr9mcu1fQVRv72lPrN4Awmow |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Are+There+Any+Racial+and+Ethnic+Differences+in+Response+to+Medicines+in+Japanese+Patients%3F&rft.jtitle=Journal+of+Atherosclerosis+and+Thrombosis&rft.au=Nakagawa%2C+Yoshihisa&rft.date=2015-01-01&rft.pub=Japan+Atherosclerosis+Society&rft.issn=1340-3478&rft.eissn=1880-3873&rft.volume=22&rft.issue=6&rft.spage=550&rft.epage=552&rft_id=info:doi/10.5551%2Fjat.ED013&rft.externalDocID=article_jat_22_6_22_ED013_article_char_en |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1340-3478&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1340-3478&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1340-3478&client=summon |